Latest NCI-designated Cancer Center Stories
MEMPHIS, Tenn., March 13, 2012 /PRNewswire/ -- Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis. To view the multimedia assets associated with this release, please click:...
Tennessee Governor Proclaims February as St. Jude Month MEMPHIS, Tenn., Feb. 4, 2012 /PRNewswire-USNewswire/ -- In 1962, St. Jude Children's Research Hospital opened its doors amid an emotionally charged debate regarding how to treat childhood cancer. At that time, few children with the most common form of childhood cancer survived, and many physicians believed treatment was futile. St. Jude physicians and researchers took a radically different approach, and these efforts proved...
Kmart, CVS/pharmacy, DICK'S Sporting Goods, Kay Jewelers, ANN INC. and others raise record-setting funds and awareness; online engagement at all-time high with $7.9 million in donations; Hispanic donations up 49% over previous year MEMPHIS, Tenn., Jan. 30, 2012 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital® is ringing in the new year by "giving thanks" to the consumers and partners who supported the eighth annual St. Jude Thanks and Giving® campaign and...
WASHINGTON, Jan. 24, 2012 /PRNewswire-USNewswire/ -- Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers. GUMC's license agreement with BioMetrx, LLC, a Maryland-headquartered biotechnology company, expedites the translation of the agent, Rasstore(TM), from the laboratory to the clinical setting for further investigation...
Office Bundle will make a $25.00 donation for every qualifying order of $80.00 or more on specially marked products. (PRWEB) January 23, 2012 Throughout 2011, online office supply provider OfficeBundle.com has joined a growing list of retailers who donated a portion of qualifying sales to City of Hope, a renowned breast cancer research and treatment center working to improve the lives of cancer patients around the world through research, innovation and compassion. This generous...
A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignancy, which kills an estimated 549,000 people worldwide annually. The animal study, by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and at Mayo Clinic, focused on microRNA-221 (miR-221), a...
Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have been treated with surgery, researchers at Mayo Clinic found. Their 778-patient study, which appeared in the Dec. 1 issue of the Journal of Clinical Oncology (http://jco.ascopubs.org/), found that five-year survival in obese patients -- those with a body mass index of 30 or higher -- with esophageal cancer was 18 percent, compared to 36 percent in patients of normal weight. The...
Jon Hamm, Elisabeth Moss, Jared Harris, John Slattery, Mila Kunis, Julie Bowen, Jesse Tyler Ferguson, Marcia Cross, Rashida Jones, Jennifer Westfeldt, Amanda Seyfried, Cindy Crawford, William Shatner, Cybill Shepherd, Jaime Pressly, Jason Bateman, Vanessa Williams, Hilary Duff, Daisy Fuentes, Harry Hamlin & Lisa Rinna, Alison Sweeney, Amber Valletta, Diahann Carroll, and more to attend event LOS ANGELES, Dec. 20, 2011 /PRNewswire-USNewswire/ -- Tony Bennett, Ray Romano and...
Study documents connection between increased levels of these lipids and cancer growth and metastasis; also opens door to new avenue for cancer treatment BOSTON, Dec. 19, 2011 /PRNewswire-USNewswire/ -- A group of small molecules called EETs - currently under scrutiny as possible treatment targets for a host of cardiovascular diseases - may also drive the growth and spread of cancer, according to researchers at the Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and other...
A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered. Researchers with the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute led the study and estimate that the mutation arose in the Middle East some 13,600 years ago. Only a mutation seen in cystic fibrosis that arose between 11,000 and 52,000 years ago...
